✦ LIBER ✦

A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma

✍ Scribed by Mary L. McMaster; David H. Johnson; John P. Greer; Steven N. Wolff; Craig R. Hildreth; F. Anthony Greco; John D. Hainsworth

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 557 KB
Volume: 67
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910315)67:6<1487::aid-cncr2820670604>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of treatment with high intensity

Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-hodgkin's lymphoma

✍ Mary L. McMaster; John P. Greer; Steven N. Wolff; David H. Johnson; F. Anthony G 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 848 KB

Immunotoxin combined with chemotherapy f

Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma

✍ David T. Scadden; David P. Schenkein; Zale Bernstein; Barry Luskey; John Doweiko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

The objective of this study was to develop and test a combined therapeutic approach for patients with AIDS-related lymphoma (ARL), employing agents with independent mechanisms of action and nonoverlapping toxicity. This study was designed to test the feasibility and tolerance of combining low dose c

Copp chemotherapy for elderly patients w

Copp chemotherapy for elderly patients with intermediate and high grade non-Hodgkin's lymphoma

✍ Dr Raymond Liang; David Todd; T. K. Chan; Edmond Chiu; Albert Lie; Faith Ho 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

Non-melanoma skin cancer may be a marker

Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma

✍ Henrik Hjalgrim; Morten Frisch; Hans H. Storm; Bengt Glimelius; Jakob Bøje Peder 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 2 views

According to recent results, patients with non-melanoma skin cancers are at increased risk of developing non-Hodgkin's lymphoma (NHL). The prognostic significance of this association is unknown. Two cohorts of patients with a first diagnosis of non-melanoma skin cancer and a subsequent diagnosis of

Salvage chemotherapy for non Hodgkin's l

Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of ccnu and vinblastine

✍ Dr. G. Palmieri; R. Lauria; F. Caponigro; C. Pagliarulo; V. Montesarchio; F. Nuz 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Twenty patients with relapsed or refractory, intermediate or high grade non Hodgkin's lymphoma were treated with a combination of CCNU and vinblastine. Complete responses occurred in four patients (20 per cent), partial responses in eight (40 per cent), for an overall response rate of 60 per cent. T

Second-line chemotherapy in human immuno

Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: Evidence of activity of a combination of etoposide, mitoxantrone, and prednimustine in relapsed patients

✍ Umberto Tirelli; Domenico Errante; Michele Spina; Roberta Gastaldi; Ezio Nigra; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

## BACKGROUND. There is very little experience reported in the literature on the treatment of patients with relapsed or resistant human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NIIL). We performed a prospective study to ovaluate the feasibility and activity of a second-line chemo